Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-09-22-Speech-3-147"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20100922.20.3-147"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Mr President, I strongly support the report on the rationalising of the pharmacovigilance system for medicinal purposes for human use. I think this is an area where the EU can certainly add value and where, by working together, we can ensure greater patient safety.
Even after medicines are fully authorised, there can still be adverse reactions, and I think the full safety profile of medicines can only be known once they have entered the market. That is why we must continue to be vigilant. This proposal will ensure greater patient safety by strengthening the EU system for monitoring the safety of medicines. It will enhance Eudravigilance, the database for collecting information on adverse drug reactions. The creation of the new European medicines safety web portal will allow citizens better access to clear and understandable information on safety issues.
This is the first part of the three-part package to strengthen and address gaps in EU pharmaceutical legislation, and I believe it is a good first step."@en1
|
| lpv:spokenAs | |
| lpv:unclassifiedMetadata | |
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples